Alice Gottlieb, MD, PhD: Dr Gottlieb served as a speaker for Amgen, Inc. and Wyeth Pharmaceuticals; has current consulting/advisory board agreements with Amgen, Inc., Centocor, Inc., Wyeth Pharmaceuticals, Celgene Corp, Bristol Myers Squibb Co, Beiersdorf, Inc, Warner Chilcott, Abbott Labs, Roche, Sankyo, Medarex, Kemia, Celera, TEVA, Actelion, UCB, Novo Nordisk, Almirall, Immune Control, RxClinical, Dermipsor Ltd, Medacorp, DermiPsor, Can-Fite, and Incyte; and has received research/educational grants from Centocor, Amgen, Wyeth, Immune Control, Celgene, Pharmacare, and Incyte. All income has been paid to her employer directly.
Neil J. Korman, MD, PhD: Dr Korman has served on the Advisory Board and was investigator and speaker for Abbott Labs, Genentech, and Astellas, receiving grants and honoraria; served on the Advisory Board and was investigator for Centocor, receiving grants and residency/ fellowship program funding; and was investigator and speaker for Amgen, receiving grants and honoraria.
Kenneth B. Gordon, MD: Dr Gordon served on the Advisory Board and was consultant, investigator, and speaker for Abbott Labs, Amgen, and was a consultant and investigator for Centocor, receiving grants and honoraria; and was investigator for Genentech, receiving grants.
Steven R. Feldman, MD, PhD: Dr Feldman served on the Advisory Board and was investigator and speaker for Galderma, Stiefel, Warner Chilcott, Abbott Labs, and Astellas, receiving grants and honoraria; served on the Advisory Board for Photomedex, receiving stock options; served on the advisory board and was speaker for National Psoriasis Foundation, receiving honoraria; and was an investigator and speaker for Amgen, Centocor, and Genentech, receiving grants and honoraria.
Mark Lebwohl, MD: Dr Lebwohl served on the Advisory Board and was consultant, investigator, and speaker for Abbott Labs, Amgen, Centocor, Galderma, Genentech, and Warner Chilcott, receiving honoraria and grants; served on the Advisory Board and was consultant, investigator, and speaker for Stiefel, receiving honoraria; was consultant and investigator for Astellas, receiving grants and honoraria; was consultant for Biogen, UCB, and Isotechnika, receiving honoraria; was on the Advisory Board and was consultant and investigator for Novartis, receiving grants and honoraria; and had an "other" relationship with PharmaDerm, receiving grants and honoraria.
John Y. M. Koo, MD: Dr Koo served on the Advisory Board, was speaker, consultant, and investigator for Amgen, Abbott Labs, Astellas, Warner Chilcott, and Galderma, receiving grants and honoraria; was investigator for Genentech, receiving grants; and was on the Advisory Board and was a consultant and investigator for Teikokio receiving no compensation.
Abby S. Van Voorhees, MD: Dr Van Voorhees served on the Advisory Board, was an investigator and speaker for Amgen and Genentech, receiving grants and honoraria; was an investigator for Astellas, IDEC, and Roche receiving grants; an Advisory Board and investigator for Bristol Myers Squibb and Warner Chilcott, receiving grants and honoraria; Advisory Board and speaker for Abbott Labs and Centocor, receiving honoraria; served on the Advisory Board for Connetics, receiving honoraria; was a consultant for Incyte and Xtrac and VGX and has received honoraria from Synta for another function. Dr. Van Voorhees' spouse is an employee with Merck receiving a salary, stock, and stock options.
Craig A. Elmets, MD: Dr Elmets has served on the Advisory Board and was investigator for Amgen and Abbott Labs, receiving grants and honoraria; was consultant for Astellas, receiving honoraria; and was an investigator for Genentech and Connetics, receiving grants.
Craig L. Leonardi, MD: Dr Leonardi served on the Advisory Board and was consultant, investigator, and speaker for Abbott Labs, Amgen, Centocor, and Genentech receiving honoraria, other financial benefits, and grants for Amgen and Genentech; was speaker for Warner Chillcott, receiving honoraria; was on the Advisory Board and was an investigator for Serano, receiving honoraria and other financial benefit; was an investigator for Astellas, Biogen, Bristol Myers, Allergan, Fujisawa, CombinatorRx, and Vitae, receiving other financial benefit.
Karl R. Beutner, MD, PhD: Chair, Clinical Research Committee. Dr Beutner was an employee of Anacor, receiving salary, stock, and stock options; and had other relationships and received stocks from Dow Pharmaceutical Sciences.
Reva Bhushan, PhD: Dr Bhushan has no relevant conflicts of interest to disclose.
Alan Menter, MD: Chair, Psoriasis Work Group. Dr Menter served on the Advisory Board and was a consultant, investigator and speaker for Abbott Labs, Amgen, and Centocor, receiving grants and honoraria; served on the Advisory Board and was an investigator and consultant for Cephalon and UCB, receiving grants and honoraria; was a consultant, investigator, and speaker for Warner Chilcott and Wyeth, receiving honoraria; served on the Advisory Board and was an investigator for Galderma and Genentech, receiving grants and honoraria; was a consultant and investigator for Allergan and Astellas, receiving grants and honoraria; was an investigator for Collagenex, CombinatoRx, Dow, Ferndale, Leo, Medicis, Photocure, Pierre Fabre, 3M Pharmaceuticals, and XOMA receiving grants; and was an investigator for Connetics, receiving grants and honorarium.
